Private-equity firm 3i invests between €100m and €150m for majority control of high-growth nutrition business Nutergia.
Private-equity firm 3i Group has acquired a 51% stake in Laboratoire Nutergia, a French sports-nutrition and supplements manufacturer. The deal values the investment between €100m and €150m, aligning with 3i’s typical equity cheque size.
Nutergia, founded in 1989, has delivered double-digit organic annual growth for over a decade. The company operates a production facility in France and sells primarily through pharmacies, with additional markets in Spain and Belgium. The Lagarde family retains a significant minority holding and will remain active in the business.
3i highlighted Nutergia’s strong brand, healthcare heritage, and alignment with its strategy of investing in companies promoting healthier lifestyles. The transaction terms remain undisclosed.